zavegepant hydrochloride · Pfizer · NDA 216386
Zavzpret
Earliest generic entry, as listed
26 Jun 2034
Blocked by patent: US 8481546.
Listed patents · 1 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 8481546 | substance, product, use U-3555 | 26 Jun 2034 |
Exclusivities · 1 unexpired
| NCE | new chemical entity (5 years) | 9 Mar 2028 |
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 216386 · 001 · RLD | spray, metered, nasal | EQ 10MG BASE/SPRAY | 26 Jun 2034 |